awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41859238-D8A107A3-32D8-4D66-BF7E-61D020B328F4
Q41859238-D8A107A3-32D8-4D66-BF7E-61D020B328F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41859238-D8A107A3-32D8-4D66-BF7E-61D020B328F4
Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm.
P2860
Q41859238-D8A107A3-32D8-4D66-BF7E-61D020B328F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41859238-D8A107A3-32D8-4D66-BF7E-61D020B328F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68dc7d14e460444888423d58087fdf9f92ca7704
P2860
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies